IP Library Granted Patent US 10,626,416
Granted Patent B2
US 10,626,416 · App. 16/548,631 · Granted Apr 21, 2020

Nucleic acid-guided nucleases

Inventors: Ryan T. Gill (Denver, CO); Andrew Garst (Boulder, CO); Tanya Elizabeth Warnecke Lipscomb (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/902C12N9/22C12N15/11C12N15/111C12N15/70C12N15/81C12N15/85C12N15/905C12N15/907C12N2310/20C12N2800/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,626,416
App. No.
16/548,631
Granted
Apr 21, 2020
Kind
B2
Abstract

Disclosed herein are nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Disclosed herein are engineered non-naturally occurring nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems, and methods of use. Targetable nuclease systems can be used to edit genetic targets, including recursive genetic engineering and trackable genetic engineering methods.

Claims (19)

1. A targetable nuclease system comprising:

(a) a nucleic acid-guided nuclease obtained from a Succinivibrio dextrinosolvens organism; and

(b) a heterologous engineered guide nucleic acid for complexing with the Succinivibrio dextrinosolvens nucleic acid-guided nuclease and hybridizing to a eukaryotic target sequence, wherein the heterologous engineered guide nucleic acid comprises a sequence from the group consisting of SEQ ID NO: 88, SEQ ID NO: 93, and SEQ ID NO: 94.

2. The system of claim 1 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens recognizes a TTTN PAM.

3. The system of claim 1 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens has an editing efficiency of between 75% to 100% as measured by dividing the number of edited cells by the total number of recovered cells.

4. The system of claim 1 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens comprises the sequence of SEQ ID NO: 2.

5. The system of claim 4 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens does not form a functional complex with an endogenous guide from the Succinivibrio dextrinosolvens organism.

6. The system of claim 1 , further comprising an editing cassette.

7. A targetable nuclease system comprising:

(a) a nucleic acid-guided nuclease obtained from a Succinivibrio dextrinosolvens organism; and

(b) an editing cassette, wherein said editing cassette comprises a polynucleotide encoding an editing sequence and a polynucleotide encoding a heterologous engineered guide nucleic acid for complexing with the Succinivibrio dextrinosolvens nucleic acid-guided nuclease, wherein the heterologous engineered guide nucleic acid comprises a sequence selected from the group consisting of SEQ ID NO: 88, SEQ ID NO: 93, and SEQ ID NO: 94, and wherein the editing sequence comprise a template for homologous recombination.

8. The system of claim 7 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens recognizes a TTTN sequence.

9. The system of claim 7 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens has an editing efficiency of between 75% to 100% as measured by dividing the number of edited cells by the total number of recovered cells.

10. The system of claim 7 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens comprises the sequence of SEQ ID NO: 2.

11. The system of claim 10 , wherein the nucleic acid-guided nuclease obtained from the Succinivibrio dextrinosolvens does not form a functional complex with an endogenous guide from the Succinivibrio dextrinosolvens organism.

12. The system of claim 7 , wherein the editing cassette is more than 500 nucleotides in length.

13. The system of claim 7 , wherein said targetable nuclease system causes a double-strand break on a target region.

14. The system of claim 13 , wherein the target region is within a eukaryotic cell.

15. The system of claim 14 , wherein the target region is within a mammalian cell.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Sep 15, 2025
From: INSCRIPTA, INC.,; MANUS INSCRIPTA, INC.
To: MANUS INSCRIPTA, INC.
Reel/Frame 072252/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2019
From: GILL, RYAN T.; GARST, ANDREW; WARNECKE LIPSCOMB, TANYA ELIZABETH
To: MUSE BIOTECHNOLOGY, INC.
Reel/Frame 050823/0039 →
CHANGE OF NAME Recorded Oct 24, 2019
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 050823/0375 →
Continuity (3)
Continuation 15896433 · Feb 14, 2018
Continuation 15631989 · Jun 23, 2017
Related Publication 20190390226A1 · Dec 26, 2019
Cited By (1)
US 12,195,749